Pancreatic Cancer Research

ResearcherKurume UniversityActive in the last 2 years

Hironori Koga

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5814-9543; OpenAlex author ID A5012513340. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Leucine drives LAT1-related SNAIL upregulation in glucose-starved pancreatic cancer cells. Last author DOI 10.1007/s00795-024-00404-0↗
  2. Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma. First author DOI 10.1016/j.gastha.2024.04.011↗
  3. Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer. First author DOI 10.1007/s00795-019-00218-5↗
  4. PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. Co-author DOI 10.3892/ijo.2011.1237↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takumi Kawaguchi · 2 shared papers, 2024–2025 · strength 0.54
  2. Hajime Masubuchi · 1 shared paper, 2025 · strength 0.37
  3. Yoshinobu Okabe · 2 shared papers, 2019–2024 · strength 0.25
  4. Takuji Torimura · 2 shared papers, 2019–2024 · strength 0.25
  5. Takahiko Sakaue · 2 shared papers, 2019–2024 · strength 0.25
  6. Toru Hisaka · 1 shared paper, 2024 · strength 0.17
  7. Yoshiki Naito · 1 shared paper, 2024 · strength 0.17
  8. Tõru Nakamura · 1 shared paper, 2024 · strength 0.17
  9. Tomoyuki Ushijima · 1 shared paper, 2019 · strength 0.08
  10. Masaru Fukahori · 1 shared paper, 2019 · strength 0.08
  11. Toru Nakamura · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.